EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited

View source ↗

Summary

The European Medicines Agency has authorized a fixed-dose combination of amlodipine besilate and valsartan (Amlodipine / Valsartan Mylan) for the treatment of h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine / Valsartan Mylan (amlodipine besilate; valsartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Mylan Pharmaceuticals Limited. Decision date: 23/07/2025